Philip J. Migliore

695 total citations
17 papers, 556 citations indexed

About

Philip J. Migliore is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Philip J. Migliore has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Oncology. Recurrent topics in Philip J. Migliore's work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Philip J. Migliore is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Philip J. Migliore collaborates with scholars based in United States, Canada and India. Philip J. Migliore's co-authors include Raymond Alexanian, Daniel E. Bergsagel, Janice B. Schwartz, Clifton D. Howe, William K. Vaughn, Kenneth M. Griffith, Dennis F. Moore, C. C. Shullenberger, Robert Roberts and David H. Yawn and has published in prestigious journals such as Science, Blood and Annals of Internal Medicine.

In The Last Decade

Philip J. Migliore

15 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip J. Migliore United States	12	222	172	126	91	86	17	556
L. Engstedt Sweden	15	178 0.8×	121 0.7×	87 0.7×	130 1.4×	50 0.6×	41	607
Owens Ah United States	11	106 0.5×	110 0.6×	156 1.2×	55 0.6×	74 0.9×	21	550
K. Sølling Denmark	17	82 0.4×	221 1.3×	103 0.8×	46 0.5×	111 1.3×	33	827
Virginia C. Canale United States	11	244 1.1×	143 0.8×	104 0.8×	430 4.7×	114 1.3×	20	841
ML Rand Canada	13	314 1.4×	78 0.5×	54 0.4×	75 0.8×	123 1.4×	20	615
F. W. Ballardie United Kingdom	17	118 0.5×	221 1.3×	63 0.5×	94 1.0×	250 2.9×	37	925
Ambrus Jl United States	11	71 0.3×	95 0.6×	94 0.7×	26 0.3×	67 0.8×	50	406
Virginia Davenport United States	12	105 0.5×	134 0.8×	136 1.1×	44 0.5×	144 1.7×	21	639
Robert O. Bash United States	11	109 0.5×	213 1.2×	240 1.9×	81 0.9×	78 0.9×	15	690
P Verroust France	11	84 0.4×	220 1.3×	56 0.4×	40 0.4×	30 0.3×	26	464

Countries citing papers authored by Philip J. Migliore

Since Specialization

Citations

This map shows the geographic impact of Philip J. Migliore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Migliore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Migliore more than expected).

Fields of papers citing papers by Philip J. Migliore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Migliore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Migliore. The network helps show where Philip J. Migliore may publish in the future.

Co-authorship network of co-authors of Philip J. Migliore

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Migliore. A scholar is included among the top collaborators of Philip J. Migliore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Migliore. Philip J. Migliore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kadmon, Dov, et al.. (1996). Pitfalls in Interpreting Prostate Specific Antigen Velocity. The Journal of Urology. 155(5). 1655–1657. 22 indexed citations

Kadmon, Dov, et al.. (1996). Pitfalls in interpreting prostate specific antigen velocity.. PubMed. 155(5). 1655–7. 27 indexed citations

Gillum, David M., et al.. (1988). CHRONIC CYCLOSPORINE NEPHROTOXICITY A RODENT MODEL. Transplantation. 46(2). 285–291. 50 indexed citations

Bennett, William R., David H. Yawn, Philip J. Migliore, et al.. (1987). Activation of the complement system by recombinant tissue plasminogen activator. Journal of the American College of Cardiology. 10(3). 627–632. 86 indexed citations

Schwartz, Janice B. & Philip J. Migliore. (1984). Effect of nifedipine on serum digoxin concentration and renal digoxin clearance. Clinical Pharmacology & Therapeutics. 36(1). 19–24. 43 indexed citations

Hayman, L. Anne & Philip J. Migliore. (1980). Contrast-Induced Renal Failure. Radiology. 137(3). 867–867.

Hayman, L. Anne & Philip J. Migliore. (1980). Contrast-induced renal failure.. Radiology. 137(3). 867–869. 11 indexed citations

Harris, Jules E., Raymond Alexanian, Evan M. Hersh, & Philip J. Migliore. (1971). Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin.. PubMed. 104(5). 389–93. 26 indexed citations

Moore, Dennis F., Philip J. Migliore, C. C. Shullenberger, & Raymond Alexanian. (1970). Monoclonal Macroglobulinemia in Malignant Lymphoma. Annals of Internal Medicine. 72(1). 43–47. 58 indexed citations

10.

Alexanian, Raymond, Daniel E. Bergsagel, Philip J. Migliore, William K. Vaughn, & Clifton D. Howe. (1968). Melphalan Therapy for Plasma Cell Myeloma. Blood. 31(1). 1–10. 112 indexed citations

11.

Migliore, Philip J. & Raymond Alexanian. (1968). Monoclonal gammopathy in human neoplasia. Cancer. 21(6). 1127–1131. 53 indexed citations

12.

Bergsagel, Daniel E., Philip J. Migliore, & Kenneth M. Griffith. (1965). Response : Melphalan and Antigenic Type of Bence Jones Proteins in Myeloma. Science. 149(3683). 565–565. 1 indexed citations

13.

Osserman, E F, Bong-Jae Lee, Leonhard Korngold, et al.. (1965). Melphalan and Antigenic Type of Bence Jones Proteins in Myeloma. Science. 149(3683). 564–565. 15 indexed citations

14.

Jirgensons, B., et al.. (1965). Structure studies on human serum γ-globulins and myeloma proteins. Archives of Biochemistry and Biophysics. 111(2). 283–295. 3 indexed citations

15.

Bergsagel, Daniel E., Philip J. Migliore, & Kenneth M. Griffith. (1965). Myeloma Proteins and the Clinical Response to Melphalan Therapy. Science. 148(3668). 376–377. 39 indexed citations

16.

Yonezawa, Daizo, Philip J. Migliore, Sylvia Capetillo, & B. Jirgensons. (1964). Structural studies on human serum γ‐globulins and myeloma proteins. II. Cleavage of disulfide bonds of the globulins with sulfite and recombination of the fragments. Die Makromolekulare Chemie. 77(1). 191–205. 8 indexed citations

17.

Sax, Sylvan M, Philip J. Migliore, & Ray H. Baughman. (1962). Preparation, analysis, and X-ray diffraction identification of barbiturate silver salts. Analytical Biochemistry. 3(2). 150–157. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact